These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 4333806)

  • 1. Specific inhibitors for angiotensin II and angiotensin I.
    Park WK; Regoli D
    Br J Pharmacol; 1971 Oct; 43(2):418P-419P. PubMed ID: 4333806
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific antagonists for the myotropic action of angiotensin II and angiotensin I on the isolated rat colon.
    Gagnon D; Park WK; Regoli D
    Br J Pharmacol; 1971 Oct; 43(2):409-10. PubMed ID: 4333805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pressor and myotropic effects and the antagonistic properties of several analogues of angiotensin II.
    Regoli D; Park WK
    Can J Physiol Pharmacol; 1972 Feb; 50(2):99-112. PubMed ID: 4336727
    [No Abstract]   [Full Text] [Related]  

  • 4. Sexual dimorphism in angiotensin II-induced hypertension and vascular alterations.
    Tatchum-Talom R; Eyster KM; Martin DS
    Can J Physiol Pharmacol; 2005 May; 83(5):413-22. PubMed ID: 15897923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prostaglandin E-1 (PGE-1) on the vascular responsiveness to norepinephrine and angiotensin in the anesthetized rat.
    Türker RK; Kaymakçalan S; Ayhan IH
    Arzneimittelforschung; 1968 Oct; 18(10):1310-2. PubMed ID: 4303564
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery.
    Dal-Ros S; Bronner C; Schott C; Kane MO; Chataigneau M; Schini-Kerth VB; Chataigneau T
    J Pharmacol Exp Ther; 2009 Feb; 328(2):478-86. PubMed ID: 18984652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of angiotensin and inhibitors.
    Regoli D; Park WK; Rioux F
    Acta Physiol Lat Am; 1974; 24(5):525-8. PubMed ID: 4377505
    [No Abstract]   [Full Text] [Related]  

  • 8. Blockade of adrenergic potentiating effect of angiotensin by 1-Sar-8-Ala-angiotensin II.
    Zimmerman BG
    J Pharmacol Exp Ther; 1973 Jun; 185(3):486-92. PubMed ID: 4351403
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of angiotensin pressor responses with diethyl-dithiocarbamate (DDC).
    Day MD; Owen DA
    Br J Pharmacol; 1969 Oct; 37(2):517P-518P. PubMed ID: 4310584
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonists of angiotensin. Substitution of an aliphatic chain to phenyl ring in position 8.
    Regoli D; Park WK; Rioux F; Chan CS
    Rev Can Biol; 1971 Dec; 30(4):319-29. PubMed ID: 4332582
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology of angiotensin.
    Regoli D; Park WK; Rioux F
    Pharmacol Rev; 1974 Jun; 26(2):69-123. PubMed ID: 4371235
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions of minoxidil with vasoconstrictive agents in isolated rat tail artery.
    Wasiński R; Godlewski G; Wróbel B; Buckzko W
    Acta Pol Pharm; 1995; 52(3):253-6. PubMed ID: 8960256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective potentiation of angiotensin-induced constriction of skeletal muscle resistance arteries by chronic elevations in dietary salt intake.
    Weber DS; Frisbee JC; Lombard JH
    Microvasc Res; 1999 May; 57(3):310-9. PubMed ID: 10329257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemistry and mechanism of new angiotensin UU antagonists: 8 C-phenylclycine analogues of [5-isoleucine] angiotensin].
    Wissmann H; Schoelkens B; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1974 Sep; 355(9):1083-96. PubMed ID: 4376799
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of angiotensin II antagonists in experimental hypertension.
    Bumpus FM; Smeby RR; Sweet C; Ferrario CM; Khosla MC
    Circ Res; 1973 May; 32():Suppl 1:150-8. PubMed ID: 4351356
    [No Abstract]   [Full Text] [Related]  

  • 16. [Specific antagonism between angiotensin II and several of its analogs].
    Myshliakova NV; Auna ZP; Indulen IuI; Klusha VE; Chipens GI
    Probl Endokrinol (Mosk); 1976; 22(3):85-9. PubMed ID: 935097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of peripheral and central effects of angiotensin II by (1-sarcosine, 8-isoleucine)angiotensin II.
    Sweet CS; Ferrario CM; Khosla MC; Bumpus FM
    J Pharmacol Exp Ther; 1973 Apr; 185(1):35-41. PubMed ID: 4348281
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rise in plasma angiotensin II and of blood pressure induced by 5-hydroxytryptamine in rats.
    Ylitalo P
    Ann Med Exp Biol Fenn; 1972; 50(4):191-4. PubMed ID: 4352050
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of chronic blockade of angiotensin II receptor on the maintenance of hypertension and vascular changes in spontaneously hypertensive rats.
    Gillies LK; Lee RM
    Can J Physiol Pharmacol; 1996 Sep; 74(9):1061-9. PubMed ID: 8960399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.